Article info

Download PDFPDF

Original article
Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegol

Authors

  1. Correspondence to Professor Xavier Hébuterne, Department of Gastroenterology and Nutrition, Archet Hospital, 151, Route Saint Antoine de Ginestière, CHU de Nice, 06202 Nice Cedex 03, France; xavier.hebuterne{at}unice.fr
View Full Text

Citation

Hébuterne X, Lémann M, Bouhnik Y, et al
Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegol

Publication history

  • Revised February 27, 2012
  • Accepted February 29, 2012
  • First published April 23, 2012.
Online issue publication 
January 04, 2013

Article Versions

  • Gut's education editor Mairi McLean discusses the paper with Xavier Hébuterne and Jean-Frédéric Colombel in the Gut podcast.

    Listen to the podcast.

    • Supplementary Data

      This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

      Files in this Data Supplement:

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.